Laboratory and instrumental parameters associated with the risk of death in the long-term follow-up period in patients after myocardial infarction

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

BACKGROUND: In patients who successfully survived the 1st year after myocardial infarction, the risk of death remains elevated.

AIM: To determine laboratory and instrumental parameters of myocardial remodeling associated with a lethal outcome in the long-term follow-up period in patients 1 year after myocardial infarction.

MATERIAL AND METHODS: The study included 184 patients 12 months after myocardial infarction: the first group — living patients at the 5-year follow-up point (n=160), the second group — deceased patients at the 5-year follow-up point (n=24). A comparative analysis of inflammation and myocardial dysfunction biomarkers, as well as echocardiographic parameters reflecting the types of left ventricular remodeling, linear dimensions of the cavities and wall thickness of the heart, chamber volumes, and ventricular systolic function was retrospectively performed. After assessing the distribution of quantitative data, the Student's t-test or Mann–Whitney U-test and the χ2 criterion for categorical data were used. The model was built on the basis of logistic regression. The ROC curve, the Hosmer–Lemeshow test, and the bootstrap method were used to assess the model itself and its reliability.

RESULTS: Patients in the second group were older (p=0.007), and more often had myocardial infarction with ST-segment elevation during hospitalization (p <0.001). Twelve months after myocardial infarction, a multidirectional pattern of changes in the level of N-terminal brain natriuretic propeptide was revealed: a decrease was registered in the first group, while an increase was registered in the second group. In the dynamics of the second group, the index of end-diastolic volume (p=0.014) and the size of left ventricular asynergy were higher (p=0.043), and the ejection fraction was lower (p=0.015) than in the first group. The model for predicting 4-year mortality in patients who survived myocardial infarction during the 1st year included such parameters as the index of the left ventricular end-diastolic volume, the content of the N-terminal fragment of the natriuretic peptide and the presence of concentric hypertrophy of the left ventricle.

CONCLUSION: In patients who survived 1 year after myocardial infarction, the long-term risk of death is associated with a set of parameters reflecting left ventricular remodeling and the development of heart failure.

Full Text

Restricted Access

About the authors

Natalia A. Mushikhina

Tomsk National Research Medical Center of the Russian Academy of Sciences

Author for correspondence.
Email: musihina@infarkta.net
ORCID iD: 0000-0002-8280-2028
SPIN-code: 9244-6574
Scopus Author ID: 6504001940

MD, Cand. Sci. (Med.), Head of Depart., Depart. of Emergency Cardiology, Scientific Depart. of Clinical Cardiology, Tyumen Cardiology Research Center, Tomsk National Research Medical Center

Russian Federation, Tomsk

Elena A. Gorbatenko

Tomsk National Research Medical Center of the Russian Academy of Sciences

Email: elena@infarkta.net
ORCID iD: 0000-0003-3675-1503
SPIN-code: 9472-4512
Scopus Author ID: 14045151200
ResearcherId: M-8298-2019

Jr. Researcher, Lab. Instrumental Diagnostics, Tyumen Cardiology Research Center

Russian Federation, Tomsk

Alina I. Teploukhova

Tomsk National Research Medical Center of the Russian Academy of Sciences

Email: TeplouhovaAI@infarkta.net
ORCID iD: 0000-0002-7268-3467
SPIN-code: 8230-8965
Scopus Author ID: 57220067896
ResearcherId: AAU-7756-2021

MD, Head of Depart., Depart. of Cardiology No. 1, Jr. Researcher, Depart. of Emergency Cardiology, Scientific Depart. of Clinical Cardiology, Tyumen Cardiology Research Center

Russian Federation, Tomsk

Elena I. Yaroslavskaya

Tomsk National Research Medical Center of the Russian Academy of Sciences

Email: Yaroslavskaya@infarkta.net
ORCID iD: 0000-0003-1436-8853
SPIN-code: 6413-5590
Scopus Author ID: 36459379400

MD, Dr. Sci. (Med.), Head of the Lab., Lab. Instrumental Diagnostics, Leading Researcher, Ultrasound Diagnostics Doctor, Tyumen Cardiology Research Center

Russian Federation, Tomsk

Olga N. Larionova

Tomsk National Research Medical Center of the Russian Academy of Sciences

Email: LarionovaON@infarkta.net
ORCID iD: 0000-0001-7721-6633
SPIN-code: 9582-0615
Scopus Author ID: 58730676400

Jr. Researcher, Depart. of Emergency Cardiology, Scientific Depart. of Clinical Cardiology, Tyumen Cardiology Research Center

Russian Federation, Tomsk

References

  1. Kruchkov DV, Artamonova GV. Long-term survival after myocardial infarction. Kardiologiia. 2016;56(6):32–35. (In Russ.) doi: 10.18565/cardio.2016.6.32-35
  2. Qing Ye, Jie Zhang, Likun Ma. Predictors of all-cause 1-year mortality in myocardial infarction patients. Medicine (Baltimore). 2020;99(29):e21288. doi: 10.1097/MD.0000000000021288
  3. Tolpygina SN, Martsevich SYu. Cardiac risk stratification in stable coronary artery disease. Clinician. 2020;14(1–2):24–33. (In Russ.) doi: 10.17650/1818-8338-2020-14-1-2-24-33
  4. Steg PG, Greenlaw N, Tardif JC, Tendera M, Ford I, Kääb S, Abergel H, Fox KM, Ferrari R. Women and men with stable coronary artery disease have similar clinical outcomes: Insights from the international prospective CLARIFY registry. Eur Heart J. 2012;33(22):2831–2840. doi: 10.1093/eurheartj/ehs289
  5. Polyakov DS, Fomin IV, Belenkov YuN, Mareev VYu, Ageev FT, Artemjeva EG, Badin YuV, Bakulina EV, Vinogradova NG, Galyavich AS, Ionova TS, Kamalov GM, Kechedzhieva SG, Koziolova NA, Malenkova VYu, Malchikova SV, Mareev YuV, Smirnova EA, Tarlovskaya EI, Shcherbinina EV, Yakushin SS. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4–14. (In Russ.) doi: 10.18087/cardio.2021.4.n1628
  6. Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.) doi: 10.15829/1560-4071-2020-4083
  7. Linthout SV, Tschöpe C. Inflammation — cause or consequence of heart failure or both? Curr Heart Fail Rep. 2017;14(4):251–265. doi: 10.1007/s11897-017-0337-9
  8. Putyatina AN, Kim LB. Cardiac extracellular matrix and postinfarction reparative fibrosis (Part 1). Vestnik of Northern (Arctic) Federal University. Series: “Medical and biological sciences”. 2016:4:54–66. (In Russ.) doi: 10.17238/issn2308-3174.2016.4.54
  9. Musikhina NA, Petelina TI, Kostousova AI, Gapon LI, Gorbatenko EA, Bessonov IS. Biomarkers of inflammation in patients with myocardial infarction and heart failure with preserved and mid-range ejection fraction: 5-year prospective follow-up. Russian Journal of Cardiology. 2020;25(12):3726. (In Russ.) doi: 10.15829/1560-4071-2020-3726
  10. Omran F, Kyrou I, Osman F, Lim VG, Randeva HS, Chatha K. Cardiovascular biomarkers: Lessons of the past and prospects for the future. Int J Mol Sci. 2022;23(10):5680. doi: 10.3390/ijms23105680
  11. Pereira-da-Silva T, Napoleao P, Pinheiro T, Selas M, Silva F, Ferreira RC, Carmo MM. Inflammation is associated with the presence and severity of chronic coronary syndrome through soluble CD40 ligand. Am J Cardiovasc Dis. 2020;10:329–339a. PMID: 33224580
  12. Napoleão P, Cabral LBP, Selas M, Freixo C, Monteiro MC, Criado MB, Costa MC, Enguita FJ, Viegas-Crespo AM, Saldanha C, Carmo MM, Ferreira RC, Pinheiro T. Stratification of ST-elevation myocardial infarction patients based on soluble CD40L longitudinal changes. Transl Res. 2016;176:95–104. doi: 10.1016/j.trsl.2016.04.005
  13. Barsukov AV, Zobnina MP, Talantseva MS. Left ventricular hypertrophy and outcomes: A five-year retrospective analysis of patients with essential hypertension. Arterial Hypertension. 2012;18(5):385–397. (In Russ.) EDN: PGCPVF
  14. Kalyuzhin VV, Teplyakov AT, Solovtsov MA, Kalyuzhina EV, Bespalova ID, Terentyeva NN. Remodeling of the left ventricle: one or several scenarios? Bulletin of Siberian Medicine. 2016;15(4):120–139. (In Russ.) doi: 10.20538/1682-0363-2016-4-120-139
  15. Movahed MR, Ramaraj R, Manrique C, Hashemzadeh M. Left ventricular hypertrophy is independently associated with all-cause mortality. Am J Cardiovasc Dis. 2022;15;12(1):38–41. PMID: 35291507
  16. Verma A, Meris A, Skali H, Ghali JK, Arnold JMO, Bourgoun M, Velazquez EJ, McMurray JJV, Kober L, Pfeffer MA, Califf RM, Solomon SD. Prognostic implications of left ventricular mass and geometry following myocardial infarction: The VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovasc Imaging. 2008;1(5):582–591. doi: 10.1016/j.jcmg.2008.05.012
  17. Nurmukhamedova EK, Shamukhamedova NS, Aripkhodzhaeva FZ. The role of neurohumoral factors in the prognosis of patients who have suffered myocardial infarction. Molodoi uchenyi. 2018;(13):83–87. (In Russ.)

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. 5-year survival of patients depending on the type of myocardial infarction; blue line — myocardial infarction with ST segment elevation; red line — myocardial infarction without ST segment elevation

Download (26KB)
3. Fig. 2. ROC curve for predicting the possibility of assessing the risk of death 12 months after myocardial infarction. AUC=0.934 (95% confidence interval 0.870–0.997; p <0.001)

Download (25KB)

© 2024 Eco-Vector